Press release
Head and Neck Cancer Market Research Report Covering Trends, Growth Opportunities, and Future Outlook
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Head and Neck Cancer Market- by Products (Cytotoxic Agents, Antimetabolites, Abitrexate/Mexate/Folex (methotrexate), Hydrea (hydroxyurea), Antitubulins, Taxotere (docetaxel), Others (Platinum Agents, Fluoropyrimidines), Platinol (cisplatin), 5-fluorouracil (5-FU), EGFR Inhibitors (mAbs), Erbitux (cetuximab), Vectibix (panitumumab), Theracim/Theraloc (nimotuzumab), EGFR Inhibitors (TKIs), Tarceva (erlotinib), Iressa (gefitinib), Tykerb/Tyverb (lapatinib), PD1 Inhibitors, Keytruda (pembrolizumab), Opdivo (nivolumab), Pipeline Drugs (Late-stage), EGFR Inhibitors (mAbs), Vectibix (panitumumab), PDL1 Inhibitors, Imfinzi (durvalumab), Bavencio (avelumab), CTLA4 Inhibitors, Yervoy (ipilimumab) and Tremelimumab), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1217
The Head and Neck Cancer Market Size is estimated to grow at a CAGR of 8.0 % during the forecast period for 2024-2031.
Head and neck cancer (HNC) primarily originates in squamous cells that line the mucosal surfaces of the head and neck, including the mouth, nose, and throat. These cancers can affect various areas, such as the salivary glands, pharynx, larynx, paranasal sinuses, nasal cavity, and oral cavity. Annually, approximately 630,000 new cases of head and neck cancer are diagnosed worldwide, making it the sixth most prevalent cancer globally. Squamous cell carcinomas, a common form of HNC, can involve the salivary glands, oral cavity, scalp, paranasal sinuses, and nasal cavities. The oral cavity is the most frequent site of HNC development, with tobacco and alcohol consumption being significant risk factors.
The rising incidence of head and neck cancers is a primary driver of market growth, supported by factors such as an aging population, increased funding for oncology research, unmet medical needs, growing market competition, an evolving regulatory environment, and enhanced government support. However, challenges such as the high cost of treatment, limitations of existing therapies, inadequate healthcare coverage, and underdeveloped healthcare infrastructure in low- and middle-income countries present substantial barriers to market expansion. Despite these challenges, continued advancements in research and development (R&D) and manufacturing processes are expected to improve drug development efficiency. However, the high failure rate of clinical trials remains a significant obstacle for emerging companies seeking to enter the global head and neck cancer market.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
North America is projected to be the dominant contributor to the head and neck cancer market throughout the forecast period. This growth is driven by factors such as the increasing prevalence of head and neck cancer, the widespread adoption of advanced medical technologies, the strong presence of leading market players, substantial healthcare spending, and heightened awareness of modern cancer treatment options.
Moreover, the Asia Pacific region is anticipated to experience significant market growth during the forecast period. The rising incidence of head and neck cancer, coupled with an expanding patient population, is expected to drive demand for effective treatment solutions. Additionally, the growth of the biopharmaceutical sector and supportive government initiatives in the region are likely to present favorable financial opportunities for manufacturers in the coming years.
Major market players operating in the Head and Neck Cancer market include
Advaxis, Inc. (US), Amgen, Inc. (US), AstraZeneca plc (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (Ono Pharmaceutical Co., Ltd.) (Japan), Cel-Sci Corporation (US), Five Prime Therapeutics, Inc. (US), GlaxoSmithKline plc (UK), Incyte Corporation (US), IRX Therapeutics, Inc. (US), MacroGenics, Inc. (US), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer, Inc., Roche Holdings AG (Genentech) (Switzerland), Viracta Therapeutics (US) among others.
Recent collaborations and agreements in the market:
• In July 2021, Novartis (Switzerland) partnered with Kura Oncology, Inc., a clinical-stage biopharmaceutical company, to assess the efficacy of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma.
• In June 2021, CEL-SCI Corporation (United States) revealed the results of a 9.5-year pivotal Phase 3 research for its immunotherapy Multikine (Leukocyte Interleukin, Injection) in the treatment of advanced (stages III and IV) primary (previously untreated) squamous cell carcinoma of the head and neck (SCCHN). In a significant head and neck cancer phase 3 study, CEL-Multikine® SCI's Immunotherapy achieved a 14.1% 5-year survival benefit (62.7% vs 48.6%) in the group undergoing surgery plus radiotherapy.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1217
Market Segments
Global Head and Neck Cancer Market, by Products, 2022-2030 (Value US$ Mn)
• Cytotoxic Agents
• Antimetabolites
• Abitrexate/ Mexate/ Folex (methotrexate)
• Hydrea (hydroxyurea)
• Antitubulins
• Taxotere (docetaxel)
• Others (Platinum Agents, Fluoropyrimidines)
• Platinol (cisplatin)
• 5-fluorouracil (5-FU)
• EGFR Inhibitors (mAbs)
• Erbitux (cetuximab)
• Vectibix (panitumumab)
• Theracim/Theraloc (nimotuzumab)
• EGFR Inhibitors (TKIs)
• Tarceva (erlotinib)
• Iressa (gefitinib)
• Tykerb/Tyverb (lapatinib)
• PD1 Inhibitors
• Keytruda (pembrolizumab)
• Opdivo (nivolumab)
• Pipeline Drugs (Late-stage)
• EGFR Inhibitors (mAbs)
• Vectibix (panitumumab)
• PDL1 Inhibitors
• Imfinzi (durvalumab)
• Bavencio (avelumab)
• CTLA4 Inhibitors
• Yervoy (ipilimumab)
• Tremelimumab
Global Head and Neck Cancer Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Head and Neck Cancer market
To receive an industry overview and future trends of the Head and Neck Cancer market
To analyze the Head and Neck Cancer market drivers and challenges
To get information on the Head and Neck Cancer market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Head and Neck Cancer market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-head-and-neck-cancer-market/1217
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Head and Neck Cancer Market Research Report Covering Trends, Growth Opportunities, and Future Outlook here
News-ID: 3985021 • Views: …
More Releases from Insightace Analytic Pvt Ltd.

4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…

Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…

E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…

E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Head
Green Dot Sign® Going Head-to-Head with Traditional Plastic ADA Signs
After the success of their groundbreaking sustainable ADA compliant interior signs, Green Dot Sign® is now offering a more affordable and adaptable option than ever before: Low profile office signs.
Nussbaum started considering environmentally-friendly manufacturing methods and products while working at his prior sign company. The idea to create signage from a wood base and non-toxic 3D printed material for lettering, braille, and pictograms was sparked by a braille sign with…
China and India are growing head to head in Companion Diagnostic market
“Asia-Pacific Companion Diagnostics Market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion.
A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps…
East and West going head to head in Asia-Pacific Food Emulsifiers Market
Asia-Pacific Food Emulsifiers Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 6.15% to reach USD 0.78 billion by 2021, from USD 0.58 billion in 2016, which amounts to a cumulative growth of USD 0.20 billion.
View Full Report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/
Download Free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/request-sample
A substance used in food manufacturing which helps to combine liquids of different thicknesses is known as…
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops
LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the…
University Students go head to head in University of Bolton’s “Sports Fiesta …
The University of Bolton Student’s Council and the Student Activities Department organized an integrated program of sporting activities around the theme "Sports Fiesta 2012" which drew a number of Universities from the Northern Emirates and Dubai.
The activities took place at UOB RAK Campus. Separate activities for male and female attendees included; badminton, basketball, chess, cricket, darts, tug-o-war, sprint race, football and volleyball matches, and other recreational games.
To coincide with the…
KnowledgetoAction Departments Go Head to Head in a Bowling Competition
London, UK ( ) October 25, 2010 - Employees of KnowledgetoAction (http://knowledgeandaction.co.uk) have been going head to head against each other in a series of team building competitions that began on September 1, 2010. Knowledge to Action believes strongly in team building and this event showcased their desire for excellent team cooperation and communication between departments, allowing for more cohesiveness within Knowledge to Action.
Most recently, each of the KnowledgetoAction…